WebNews
Please enter a web search for web results.
NewsWeb
OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
1+ week, 4+ day ago (433+ words) Ocugen OCGN announced that enrollment and dosing have been completed in the phase II/III GARDian3 pivotal confirmatory study evaluating its pipeline candidate, OCU410 ST, for the treatment of Stargardt disease. The milestone was achieved in less than nine months, ahead of…...
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
5+ day, 18+ hour ago (826+ words) ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN " (fluocinolone acetonide intravitreal. .. ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology PRINCETON, N. J. , April…...
Frontiers | Unveiling the non-linear synergistic effects of smoking and aging on cataract-AMD comorbidity: an explainable artificial intelligence approach
7+ hour, 49+ min ago (580+ words) Frontiers in Public Health Mohammad Rocky Khan Chowdhury Front. Public Health, 13 April 2026 Sec. Aging and Public Health The comorbidity of cataract and age-related macular degeneration (AMD) poses a significant public health burden. Traditional linear statistical models often fail to capture…...
Manhasset eye surgeon on training future doctors, never too late for clear vision
1+ week, 14+ hour ago (404+ words) For Dr. James Kelly, a nationally recognized ophthalmologist and refractive surgeon, Manhasset has long been more than just a place to live. It is home. Kelly, who grew up in Queens, has lived in Manhasset since 2001, raising four children who…...
New microscope technique clearly visualizes corneal nerves and immune cells
3+ day, 16+ hour ago (219+ words) A South Korean research team has developed a microscopy technique that provides clear, simultaneous views of nerves and immune cells within the cornea without any injections. The technology is gaining attention for its potential for broad applications in treating ophthalmic…...
EYLEA HD" (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (w AMD) and Diabetic Macular Edema (DME)
1+ week, 3+ day ago (467+ words) Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regimen allows patients with w AMD and DME to be treated…...
Wegovy may have highest "eye stroke" and sight loss risk of semaglutide GLP-1 agonists
1+ mon, 3+ day ago (815+ words) Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic and 3 times higher in men than in women, analysis of unintended side effect reports shows Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk…...
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
1+ week, 7+ hour ago (540+ words) Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and events taking place during the American Society of Cataract and…...
Understanding Cataracts and Advances in Surgical Treatment
1+ week, 6+ day ago (1269+ words) Cataract remains one of the biggest drivers of avoidable vision loss in India, and the scale of surgical demand is visible in public programme data. Under the National Programme for Control of Blindness & Visual Impairment (NPCBVI), the Government of India…...
Transscleral Micropulse Cyclophotocoagulation for the Treatment of Refractory Primary Congenital Glaucoma: A Case Series
1+ day, 7+ hour ago (260+ words) Primary congenital glaucoma is a rare but vision-threatening disease. Transscleral micropulse cyclophotocoagulation (MPCPC) delivers diode laser energy in short pulses with intervening off periods, allowing tissue cooling and potentially reducing adjacent thermal damage. However, evidence on MPCPC for childhood glaucoma…...